Bioprospecting of inhibitors of EPEC virulence from metabolites of marine actinobacteria from the Arctic Sea

A considerable number of antibacterial agents are derived from bacterial metabolites. Similarly, numerous known compounds that impede bacterial virulence stem from bacterial metabolites. Enteropathogenic Escherichia coli (EPEC) is a notable human pathogen causing intestinal infections, particularly...

Full description

Bibliographic Details
Main Authors: Pylkkö, Tuomas, Schneider, Yannik Karl-Heinz, Rämä, Teppo, Andersen, Jeanette Hammer, Tammela, Päivi
Other Authors: Division of Pharmaceutical Biosciences, Bioactivity Screening Group, Drug Research Program, Faculty of Pharmacy, University of Helsinki, Divisions of Faculty of Pharmacy
Format: Article in Journal/Newspaper
Language:English
Published: Frontiers Media 2024
Subjects:
Online Access:http://hdl.handle.net/10138/586381
_version_ 1821788918870179840
author Pylkkö, Tuomas
Schneider, Yannik Karl-Heinz
Rämä, Teppo
Andersen, Jeanette Hammer
Tammela, Päivi
author2 Division of Pharmaceutical Biosciences
Bioactivity Screening Group
Drug Research Program
Faculty of Pharmacy
University of Helsinki
Divisions of Faculty of Pharmacy
author_facet Pylkkö, Tuomas
Schneider, Yannik Karl-Heinz
Rämä, Teppo
Andersen, Jeanette Hammer
Tammela, Päivi
author_sort Pylkkö, Tuomas
collection HELDA – University of Helsinki Open Repository
description A considerable number of antibacterial agents are derived from bacterial metabolites. Similarly, numerous known compounds that impede bacterial virulence stem from bacterial metabolites. Enteropathogenic Escherichia coli (EPEC) is a notable human pathogen causing intestinal infections, particularly affecting infant mortality in developing regions. These infections are characterized by microvilli effacement and intestinal epithelial lesions linked with aberrant actin polymerization. This study aimed to identify potential antivirulence compounds for EPEC infections among bacterial metabolites harvested from marine actinobacteria (Kocuria sp. and Rhodococcus spp.) from the Arctic Sea by the application of virulence-based screening assays. Moreover, we demonstrate the suitability of these antivirulence assays to screen actinobacteria extract fractions for the bioassay-guided identification of metabolites. We discovered a compound in the fifth fraction of a Kocuria strain that interferes with EPEC-induced actin polymerization without affecting growth. Furthermore, a growth-inhibiting compound was identified in the fifth fraction of a Rhodococcus strain. Our findings include the bioassay-guided identification, HPLC-MS-based dereplication, and isolation of a large phospholipid and a likely antimicrobial peptide, demonstrating the usefulness of this approach in screening for compounds capable of inhibiting EPEC virulence. Peer reviewed
format Article in Journal/Newspaper
genre Arctic
Arctic
genre_facet Arctic
Arctic
geographic Arctic
geographic_facet Arctic
id ftunivhelsihelda:oai:helda.helsinki.fi:10138/586381
institution Open Polar
language English
op_collection_id ftunivhelsihelda
op_relation 10.3389/fmicb.2024.1432475
Finlands Akademi
358776
TP acknowledges mobility funding from EU-OPENSCREEN ERIC and NordForsk for the Nordic University Hub project #85352 (Nordic POP, Patient Oriented Products), which allowed onsite visit to MARBIO/UiT-The Arctic University of Norway. The work on compound identification and isolation was supported by UiT The Arctic University of Norway and Tromsø Forskningstiftelse (grant 2520855, Center for New Antibacterial Strategies).
RIS: urn:F54268D538A64EBDDA73153B7A4CB0B5
http://hdl.handle.net/10138/586381
85203985941
001310373400001
op_rights cc_by
info:eu-repo/semantics/openAccess
openAccess
publishDate 2024
publisher Frontiers Media
record_format openpolar
spelling ftunivhelsihelda:oai:helda.helsinki.fi:10138/586381 2025-01-16T19:52:52+00:00 Bioprospecting of inhibitors of EPEC virulence from metabolites of marine actinobacteria from the Arctic Sea Pylkkö, Tuomas Schneider, Yannik Karl-Heinz Rämä, Teppo Andersen, Jeanette Hammer Tammela, Päivi Division of Pharmaceutical Biosciences Bioactivity Screening Group Drug Research Program Faculty of Pharmacy University of Helsinki Divisions of Faculty of Pharmacy 2024-10-01T09:24:03Z 12 application/pdf http://hdl.handle.net/10138/586381 eng eng Frontiers Media 10.3389/fmicb.2024.1432475 Finlands Akademi 358776 TP acknowledges mobility funding from EU-OPENSCREEN ERIC and NordForsk for the Nordic University Hub project #85352 (Nordic POP, Patient Oriented Products), which allowed onsite visit to MARBIO/UiT-The Arctic University of Norway. The work on compound identification and isolation was supported by UiT The Arctic University of Norway and Tromsø Forskningstiftelse (grant 2520855, Center for New Antibacterial Strategies). RIS: urn:F54268D538A64EBDDA73153B7A4CB0B5 http://hdl.handle.net/10138/586381 85203985941 001310373400001 cc_by info:eu-repo/semantics/openAccess openAccess 11832 Microbiology and virology Article publishedVersion 2024 ftunivhelsihelda 2024-10-10T00:14:43Z A considerable number of antibacterial agents are derived from bacterial metabolites. Similarly, numerous known compounds that impede bacterial virulence stem from bacterial metabolites. Enteropathogenic Escherichia coli (EPEC) is a notable human pathogen causing intestinal infections, particularly affecting infant mortality in developing regions. These infections are characterized by microvilli effacement and intestinal epithelial lesions linked with aberrant actin polymerization. This study aimed to identify potential antivirulence compounds for EPEC infections among bacterial metabolites harvested from marine actinobacteria (Kocuria sp. and Rhodococcus spp.) from the Arctic Sea by the application of virulence-based screening assays. Moreover, we demonstrate the suitability of these antivirulence assays to screen actinobacteria extract fractions for the bioassay-guided identification of metabolites. We discovered a compound in the fifth fraction of a Kocuria strain that interferes with EPEC-induced actin polymerization without affecting growth. Furthermore, a growth-inhibiting compound was identified in the fifth fraction of a Rhodococcus strain. Our findings include the bioassay-guided identification, HPLC-MS-based dereplication, and isolation of a large phospholipid and a likely antimicrobial peptide, demonstrating the usefulness of this approach in screening for compounds capable of inhibiting EPEC virulence. Peer reviewed Article in Journal/Newspaper Arctic Arctic HELDA – University of Helsinki Open Repository Arctic
spellingShingle 11832 Microbiology and virology
Pylkkö, Tuomas
Schneider, Yannik Karl-Heinz
Rämä, Teppo
Andersen, Jeanette Hammer
Tammela, Päivi
Bioprospecting of inhibitors of EPEC virulence from metabolites of marine actinobacteria from the Arctic Sea
title Bioprospecting of inhibitors of EPEC virulence from metabolites of marine actinobacteria from the Arctic Sea
title_full Bioprospecting of inhibitors of EPEC virulence from metabolites of marine actinobacteria from the Arctic Sea
title_fullStr Bioprospecting of inhibitors of EPEC virulence from metabolites of marine actinobacteria from the Arctic Sea
title_full_unstemmed Bioprospecting of inhibitors of EPEC virulence from metabolites of marine actinobacteria from the Arctic Sea
title_short Bioprospecting of inhibitors of EPEC virulence from metabolites of marine actinobacteria from the Arctic Sea
title_sort bioprospecting of inhibitors of epec virulence from metabolites of marine actinobacteria from the arctic sea
topic 11832 Microbiology and virology
topic_facet 11832 Microbiology and virology
url http://hdl.handle.net/10138/586381